This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Janssen Pharmaceuticals, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Luis Gauchalla: Innovator in Medical Antibody Development
Introduction
Luis Gauchalla is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of medical research, particularly in the development of antibodies for multi-drug resistant strains of bacteria. With a total of 2 patents, Gauchalla's work is paving the way for advancements in medical diagnostics and treatment.
Latest Patents
Gauchalla's latest patents include the innovative MDRimmunogen. This invention relates to an isolated antibody that specifically binds to the O25b antigen of multi-drug resistant (MDR) strains. The patent details its medical and diagnostic use, the method of producing the antibody, and includes an isolated nucleotide sequence, plasmids, and host cells used in the production process. Furthermore, it describes an isolated epitope recognized by the specific antibody, showcasing the depth of research and development involved in this project.
Career Highlights
Luis Gauchalla is currently employed at Janssen Pharmaceuticals, Inc., where he continues to push the boundaries of medical research. His work focuses on creating solutions for pressing health issues, particularly those related to antibiotic resistance. Gauchalla's dedication to innovation in the pharmaceutical industry is evident in his research and patent filings.
Collaborations
Throughout his career, Gauchalla has collaborated with talented professionals in the field. Notable coworkers include Eszter Nagy and Valéria Szijárto, who contribute to the dynamic research environment at Janssen Pharmaceuticals, Inc. Their collective expertise enhances the potential for groundbreaking discoveries in medical science.
Conclusion
Luis Gauchalla's contributions to the field of medical research through his patents and collaborations highlight his role as an innovator in the industry. His work on MDRimmunogen is a testament to the importance of developing effective treatments for multi-drug resistant strains. Gauchalla's ongoing efforts will undoubtedly continue to impact the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile